Startup India Government of India
Neoliva Life Science Private Limited
Neoliva Life Science Private Limited - business services in Pune, Maharashtra, India. Directors, charges & compliance details.
Revenue · FY 2024
₹25.55 Lakh
▼ 13% YoY
Net profit · FY 2024
₹76,862
Net margin 3%
EBITDA · FY 2024
₹2.56 Lakh
EBITDA margin 10%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Neoliva Life Science Private Limited
Data last updated:
Neoliva Life Science Private Limited is a private limited company based in Pune, Maharashtra, India, recognised as a startup by DPIIT. It operates in the service-based operations segment of the business services sector. It was incorporated on 08 August 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U74990PN2017PTC171905.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Laxmanrao Manikrao Shirfule and Amol Laxmanrao Shirfule.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sno.209/2 Bldc – 2Fl – 18 Vrindawan Co – Op Hou. Soc. Ashok Nagar Range Hills Road., Pune, Maharashtra, India – 411007.
As per the financials filed for FY 2024, the company reported a revenue of ₹25.55 Lakh, a decline of 13% compared to the previous year. For the same year it recorded a net profit of ₹76,862 (net margin 3%) and EBITDA of ₹2.56 Lakh (EBITDA margin 10%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years and 58% over five years.
Neoliva Life Science Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-21-0036557). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74990PN2017PTC171905
Registration Number 171905
Incorporation Date 08 August 2017
ROC Pune
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-MH-21-0036557
Recognitions & Rankings of Neoliva Life Science
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-MH-21-0036557
Contact details
Neoliva Life Science Private Limited's registered office is in Pune, Maharashtra.
- Registered AddressSno.209/2 Bldc – 2Fl – 18 Vrindawan Co – Op Hou. Soc. Ashok Nagar Range Hills Road., Pune, Maharashtra, India – 411007
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
Comprehensive company report
Neoliva Life Science Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Neoliva Life Science is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Neoliva Life Science Private Limited, buy the company report.
Financials of Neoliva Life Science Private Limited
FY 2025 filings availableNeoliva Life Science Private Limited reported revenue of ₹25.55 Lakh (down 13% YoY) for FY 2024.
Revenue · FY 2024
₹25.55 Lakh ▼ 13%
Net profit · FY 2024
₹76,862 margin 3%
EBITDA · FY 2024
₹2.56 Lakh margin 10%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 13%
3 years · compounded
▼ 21%
5 years · compounded
▲ 58%
EBITDA CAGR growth
1 year
▼ 28%
3 years · compounded
▼ 26%
5 years · compounded
▲ 36%
Revenue fell 13% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 58%. EBITDA fell 28% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.56 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹76,862 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10% | ||||
| Net Profit Margin | 3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Neoliva Life Science Private Limited, buy the company report.
Board of directors of Neoliva Life Science Private Limited
Neoliva Life Science has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Laxmanrao Manikrao Shirfule | Director | 26 Jul 2018 | 8 Years 3 Months | Current |
| Amol Laxmanrao Shirfule | Director | 08 Aug 2017 | 9 Years 3 Months | Current |
Peer comparison
Neoliva Life Science Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| V S R Life Sciences Private Limited | ₹25.65 Lakh (FY 2019) | Hyderabad, Telangana, India | ||||
| Aras Remedies Private Limited | ₹25.63 Lakh (FY 2025) | 30.0% | Anand, Gujarat, India | |||
| Unico Consumer Products Private Limited | ₹25.59 Lakh (FY 2022) | -53.0% | Mumbai, Maharashtra, India | |||
| Allzweck Life Sciences Private Limited | ₹25.58 Lakh (FY 2025) | -89.0% | New Delhi, Delhi, India | |||
| Krupa Labs (OPC) Private Limited | ₹25.55 Lakh (FY 2025) | -13.0% | Delhi, India | |||
| Neoliva Life Science Private Limitedthis company | ₹25.55 Lakh (FY 2024) | ₹76,862 | 3% | -13.0% | Pune, Maharashtra, India | |
| Tasyca Pharma Private Limited | ₹25.52 Lakh (FY 2025) | -30.0% | Bangalore, Karnataka, India | |||
| Afore Healthcare Private Limited | ₹25.52 Lakh (FY 2025) | -15.0% | Patna, Bihar, India | |||
| Lavanya Chemtech (India) Private Limited | ₹25.48 Lakh (FY 2018) | -52.0% | Indore, Madhya Pradesh, India | |||
| Vicrics Pharma Private Limited | ₹25.48 Lakh (FY 2025) | -13.0% | Delhi, India | |||
| Vissenta Healthcare Private Limited | ₹25.48 Lakh (FY 2024) | -26.0% | Chandigarh, India |
To see the full peer comparison of Neoliva Life Science Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Neoliva Life Science Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Neoliva Life Science Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Neoliva Life Science Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Neoliva Life Science Private Limited has 4 board changes on record since 2017: 2 appointments and 2 cessations. The latest: Laxmanrao Manikrao Shirfule ceased to be Additional Director on 31 Dec 2020.
AGM
Neoliva Life Science Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Neoliva Life Science Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune.
Ceased
Laxmanrao Manikrao Shirfule ceased to be Additional Director.
Ceased
Aatish Jayprakash Salunke ceased to be Director.
Appointed
Laxmanrao Manikrao Shirfule was appointed as Director.
Appointed
Amol Laxmanrao Shirfule was appointed as Director.
Incorporation
08 Aug 2017
Neoliva Life Science Private Limited was registered on 08 Aug 2017 with Roc Pune & aged 9 years 3 months as per MCA records.
Frequently asked questions
Neoliva Life Science is an active private limited company based in Pune, Maharashtra, India. The company works in other services, within the business services industry. It was incorporated on 08 August 2017 (9+ years old) and is registered under CIN U74990PN2017PTC171905.
Neoliva Life Science has 2 current directors:
- Laxmanrao Manikrao Shirfule - Director
- Amol Laxmanrao Shirfule - Director
The latest financial statements of Neoliva Life Science on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The CIN (Corporate Identification Number) of Neoliva Life Science is U74990PN2017PTC171905. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Neoliva Life Science was incorporated on 08 August 2017, making it 9+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Neoliva Life Science by revenue are V S R Life Sciences Private Limited, Aras Remedies Private Limited, Unico Consumer Products Private Limited, Allzweck Life Sciences Private Limited, Krupa Labs (OPC) Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Laxmanrao Manikrao Shirfule ceased to be Additional Director on 31 Dec 2020. Aatish Jayprakash Salunke ceased to be Director on 28 Jul 2018. Laxmanrao Manikrao Shirfule was appointed as Director on 26 Jul 2018. Neoliva Life Science has 4 board changes on record in total.
Yes, Neoliva Life Science is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Neoliva Life Science is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-21-0036557).
The registered office of Neoliva Life Science is at Sno.2092 Bldc – 2Fl – 18 Vrindawan Co – Op Hou. Soc. Ashok Nagar Range Hills Road., Pune, Maharashtra, India – 411007.
Neoliva Life Science operates in the business services industry, in the other services segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages